CU23049A3 - Dihidropirimidinas. - Google Patents

Dihidropirimidinas.

Info

Publication number
CU23049A3
CU23049A3 CU20000220A CU20000220A CU23049A3 CU 23049 A3 CU23049 A3 CU 23049A3 CU 20000220 A CU20000220 A CU 20000220A CU 20000220 A CU20000220 A CU 20000220A CU 23049 A3 CU23049 A3 CU 23049A3
Authority
CU
Cuba
Prior art keywords
dihydropirimidins
Prior art date
Application number
CU20000220A
Other languages
English (en)
Inventor
Joern Stoelting
Juergen Stoltefuss
Siegfried Goldmann
Thomas Kraemer
Karl-Heinz Schlemmer
Ulrich Niewoehner
Arnold Paessens
Erwin Graef
Stefan Lottmann
Karl Deres
Olaf Weber
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CU23049A3 publication Critical patent/CU23049A3/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
CU20000220A 1998-04-18 1999-04-07 Dihidropirimidinas. CU23049A3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19817264A DE19817264A1 (de) 1998-04-18 1998-04-18 Neue Dihydropyrimidine
PCT/EP1999/002344 WO1999054326A1 (de) 1998-04-18 1999-04-07 Dihydropyrimidine

Publications (1)

Publication Number Publication Date
CU23049A3 true CU23049A3 (es) 2005-06-24

Family

ID=7864972

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20000220A CU23049A3 (es) 1998-04-18 1999-04-07 Dihidropirimidinas.

Country Status (37)

Country Link
US (3) US6696451B1 (es)
EP (1) EP1080086B1 (es)
JP (2) JP4590097B2 (es)
KR (1) KR100636771B1 (es)
CN (1) CN1159311C (es)
AR (1) AR018187A1 (es)
AT (1) ATE223401T1 (es)
AU (1) AU740318B2 (es)
BG (1) BG64649B1 (es)
BR (2) BRPI9917862B8 (es)
CA (1) CA2328780C (es)
CO (1) CO5021127A1 (es)
CU (1) CU23049A3 (es)
CZ (1) CZ293482B6 (es)
DE (2) DE19817264A1 (es)
DK (1) DK1080086T3 (es)
ES (1) ES2183548T3 (es)
GT (1) GT199900056A (es)
HK (1) HK1039119A1 (es)
HU (1) HUP0102372A3 (es)
ID (1) ID27263A (es)
IL (2) IL138584A0 (es)
MY (1) MY126527A (es)
NO (2) NO321985B1 (es)
NZ (1) NZ507569A (es)
PE (1) PE20000427A1 (es)
PL (1) PL193898B1 (es)
PT (1) PT1080086E (es)
RU (1) RU2245881C9 (es)
SI (1) SI1080086T1 (es)
SK (1) SK286407B6 (es)
SV (1) SV1999000047A (es)
TR (1) TR200003011T2 (es)
TW (1) TW548274B (es)
UA (1) UA63998C2 (es)
WO (1) WO1999054326A1 (es)
ZA (1) ZA200005136B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4289100A (en) * 1999-03-25 2000-10-16 Bayer Aktiengesellschaft Dihydropyrimidines and their use in the treatment of hepatitis
EP1193259A4 (en) 1999-06-23 2003-01-29 Ajinomoto Kk dihydropyrimidine
WO2001045712A1 (de) * 1999-12-22 2001-06-28 Bayer Aktiengesellschaft Arzneimittelkombinationen gegen virale erkrankungen
DE10012823A1 (de) 2000-03-16 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10013125A1 (de) * 2000-03-17 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10013126A1 (de) * 2000-03-17 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10125131A1 (de) * 2001-05-23 2002-12-05 Bayer Ag Verfahren zur Spaltung des Methyl 4-(2-chlor-4-fluorphenyl)-2-(3,5-difluor-2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrmidincarboxylat-Racemats
US20040092735A1 (en) * 2002-11-08 2004-05-13 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefuroxime sodium
CN101104604B (zh) * 2006-07-10 2011-03-02 北京摩力克科技有限公司 光学纯二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
CN101104617B (zh) 2006-07-10 2010-06-23 北京摩力克科技有限公司 二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
RU2452733C2 (ru) * 2007-04-27 2012-06-10 Пэдью Фарма Л.П. Антагонисты trpv1 и их применение
DK2514750T5 (en) * 2007-06-18 2014-02-17 Sunshine Lake Pharma Co Ltd BROMPHENYL-SUBSTITUTED THIAZOLYLDIHYDROPYRIMIDINES
CN101686938B (zh) 2007-07-12 2012-09-05 诺瓦提斯公司 包含替比夫定的口服药物溶液
US20130267517A1 (en) 2012-03-31 2013-10-10 Hoffmann-La Roche Inc. Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
DK2888241T3 (en) 2012-08-24 2017-10-23 Sunshine Lake Pharma Co Ltd 2,4,5,6-Substituted 3,6-dihydropyrimidine derivatives such as hepatitis B virus (HBV) polymerase inhibitors for the treatment of, for example, chronic hepatitis
WO2014037480A1 (en) 2012-09-10 2014-03-13 F. Hoffmann-La Roche Ag 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
CN103664899B (zh) * 2012-09-11 2017-06-16 广东东阳光药业有限公司 杂芳基取代的二氢嘧啶类化合物及其在药物中的应用
EP2917184A4 (en) * 2012-11-09 2016-06-29 Univ Indiana Res & Tech Corp ALTERNATIVE USES FOR HBV ARRANGEMENT EFFECTORS
GB2582067B (en) 2013-03-15 2021-02-24 Fisher & Paykel Healthcare Ltd Components for medical circuits
TW201609652A (zh) * 2013-11-12 2016-03-16 陶氏農業科學公司 用於氟化化合物之過程(三)
MX2016006564A (es) 2013-11-19 2017-09-12 Sunshine Lake Pharma Co Ltd Compuestos dihidropirimidina y su aplicacion en productos farmaceuticos.
JP6434511B2 (ja) 2013-11-27 2018-12-05 サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. ジヒドロピリミジン誘導体およびその中間体の製造方法
EP3122747B1 (en) 2014-03-28 2020-05-20 North & South Brother Pharmacy Investment Company Limited Dihydropyrimidine compounds and their application in pharmaceuticals
CN105153164B (zh) * 2014-05-30 2018-10-30 齐鲁制药有限公司 作为hbv抑制剂的二氢嘧啶并环衍生物
BR112016028000B1 (pt) * 2014-05-30 2022-05-17 Qilu Pharmaceutical Co., Ltd Derivado de alça de di-hidropirimido como um inibidor de hbv
WO2016124126A1 (en) 2015-02-07 2016-08-11 Sunshine Lake Pharma Co., Ltd. Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals
WO2019001420A1 (en) * 2017-06-27 2019-01-03 Janssen Pharmaceutica Nv HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING INFECTIONS WITH HEPATITIS B VIRUS
US10759774B2 (en) 2017-09-28 2020-09-01 The Curators Of The University Of Missouri Inhibitors of hepatitis B virus targeting capsid assembly
GEP20227374B (en) 2017-11-02 2022-04-25 Aicuris Gmbh & Co Kg Novel, highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hepatitis b virus (hbv)
AR113826A1 (es) 2017-11-02 2020-06-17 Aicuris Gmbh & Co Kg Indol-2-carboxamidas sustituidas con amino-tiazol activas contra el virus de la hepatitis b (vhb)
EP3790866A4 (en) * 2018-05-08 2022-03-02 Janssen Sciences Ireland Unlimited Company DIHYDROPYRIMIDE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASE
US11053235B2 (en) 2018-08-09 2021-07-06 Janssen Sciences Ireland Unlimited Company Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseases
AR117188A1 (es) 2018-11-02 2021-07-21 Aicuris Gmbh & Co Kg Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (vhb)
UY38434A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Nuevas 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activas contra el virus de la hepatitis b (hbv)
AR116948A1 (es) 2018-11-02 2021-06-30 Aicuris Gmbh & Co Kg Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (vhb)
US20220009945A1 (en) * 2018-11-02 2022-01-13 Aicuris Gmbh & Co. Kg Novel urea 6,7-dihydro-4h-thiazole[5,4-c]pyridines active against the hepatitis b virus (hbv)
AR116947A1 (es) 2018-11-02 2021-06-30 Aicuris Gmbh & Co Kg Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas-indol-2-carboxamidas activas contra el virus de la hepatitis b (vhb)
UY38439A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Novedosas urea 6,7-dihidro-4h-pirazolo[4,3-c]piridinas activas contra el virus de la hepatitis b (vhb)
JP2022511819A (ja) 2018-12-20 2022-02-01 ヤンセン ファーマシューティカ エヌ.ベー. ヘテロアリールジヒドロピリミジン誘導体及びb型肝炎感染症を治療する方法
CN113767102A (zh) 2019-04-30 2021-12-07 艾库里斯有限及两合公司 具有抗乙型肝炎病毒(hbv)活性的新的苯基和吡啶基脲类化合物
CN113748113A (zh) 2019-04-30 2021-12-03 艾库里斯有限及两合公司 具有抗乙型肝炎病毒(hbv)活性的新型吲哚嗪-2-甲酰胺类化合物
EP3962914A1 (en) 2019-04-30 2022-03-09 AiCuris GmbH & Co. KG Novel indole-2-carboxamides active against the hepatitis b virus (hbv)
MX2021013105A (es) 2019-04-30 2021-11-17 Aicuris Gmbh & Co Kg Nuevas oxalil piperazinas activas contra el virus de la hepatitis b (vhb).
WO2020255016A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH550189A (de) 1971-01-08 1974-06-14 Ciba Geigy Ag Verfahren zur herstellung von neuen dibenzo (b,f) thiepincarbonsaeuren.
CH569043A5 (es) 1973-01-23 1975-11-14 Ciba Geigy Ag
US4371537A (en) * 1981-08-13 1983-02-01 The Dow Chemical Company Sulfur-substituted phenoxypyridines having antiviral activity
DE3234684A1 (de) * 1982-09-18 1984-03-22 Bayer Ag, 5090 Leverkusen Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS60185764A (ja) 1984-03-05 1985-09-21 Wako Pure Chem Ind Ltd ピリジン誘導体の新規な製造法
US4698340A (en) 1984-07-19 1987-10-06 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives, processes for preparation thereof and composition containing the same
US4727073A (en) 1984-10-01 1988-02-23 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives and composition of the same
GB8906168D0 (en) 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
KR20000053201A (ko) * 1996-11-12 2000-08-25 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 제초제로서 유용한 피라졸 유도체
SE9702564D0 (sv) 1997-07-02 1997-07-02 Astra Ab New compounds

Also Published As

Publication number Publication date
CZ20003871A3 (cs) 2001-01-17
ATE223401T1 (de) 2002-09-15
WO1999054326A8 (de) 1999-12-29
NZ507569A (en) 2002-04-26
AU3813399A (en) 1999-11-08
SK15652000A3 (sk) 2001-04-09
ID27263A (id) 2001-03-22
GT199900056A (es) 2000-10-07
BR9909730B1 (pt) 2012-09-04
SK286407B6 (sk) 2008-09-05
SI1080086T1 (en) 2003-02-28
US6696451B1 (en) 2004-02-24
NO20045259L (no) 2000-12-13
CA2328780C (en) 2008-09-23
NO329020B1 (no) 2010-07-26
BRPI9917862B1 (pt) 2013-05-07
PT1080086E (pt) 2002-12-31
KR100636771B1 (ko) 2006-10-23
DE59902573D1 (en) 2002-10-10
PL193898B1 (pl) 2007-03-30
CZ293482B6 (cs) 2004-05-12
TW548274B (en) 2003-08-21
CO5021127A1 (es) 2001-03-27
BR9909730A (pt) 2000-12-19
JP2010241837A (ja) 2010-10-28
EP1080086B1 (de) 2002-09-04
IL138584A0 (en) 2001-10-31
MY126527A (en) 2006-10-31
SV1999000047A (es) 2000-06-23
JP5237332B2 (ja) 2013-07-17
NO321985B1 (no) 2006-07-31
NO20005215D0 (no) 2000-10-17
RU2245881C9 (ru) 2006-02-10
BG104812A (en) 2001-06-29
CA2328780A1 (en) 1999-10-28
HK1039119A1 (en) 2002-04-12
BRPI9917862A2 (es) 2010-12-07
PL343481A1 (en) 2001-08-27
CN1305471A (zh) 2001-07-25
AU740318B2 (en) 2001-11-01
DK1080086T3 (da) 2002-12-23
HUP0102372A2 (hu) 2001-12-28
IL138584A (en) 2006-09-05
BG64649B1 (bg) 2005-10-31
WO1999054326A1 (de) 1999-10-28
RU2245881C2 (ru) 2005-02-10
ES2183548T3 (es) 2003-03-16
UA63998C2 (uk) 2004-02-16
KR20010042788A (ko) 2001-05-25
US7514565B2 (en) 2009-04-07
ZA200005136B (en) 2001-03-02
TR200003011T2 (tr) 2001-01-22
DE19817264A1 (de) 1999-10-21
BRPI9917862B8 (pt) 2021-05-25
JP2002512243A (ja) 2002-04-23
NO20005215L (no) 2000-12-13
EP1080086A1 (de) 2001-03-07
US20040167135A1 (en) 2004-08-26
US20070117812A1 (en) 2007-05-24
AR018187A1 (es) 2001-10-31
PE20000427A1 (es) 2000-06-25
JP4590097B2 (ja) 2010-12-01
HUP0102372A3 (en) 2003-01-28
CN1159311C (zh) 2004-07-28

Similar Documents

Publication Publication Date Title
CU23049A3 (es) Dihidropirimidinas.
TR199902372A3 (tr) Sulfanilsilanlar.
IT1312540B1 (it) Composto.
MA26849A1 (fr) 4-pyridinyle-n-acyl-l-phenylalanines.
ITBO990359A0 (it) Elettromandrino .
DE60029755D1 (de) Congawandschutz.
ITBO990358A0 (it) Elettromandrino .
ES1036909Y (es) Pupitre infantil.
ES1037395Y (es) Tendedero antilluvia.
ES1040589Y (es) Expositor-dispensador.
ES1042117Y (es) Mesa-sombrilla.
ES1040633Y (es) Escalifono.
ES1040343Y (es) Carrito portafregona.
ES1039730Y (es) Rodapie.
ES1040731Y (es) Gafa.
ES1041028Y (es) Formulario de correspondencia.
ITNA980067A1 (it) Bloccatappo.
ITBO980260A1 (it) Riavvolgicarta.
ES1040336Y (es) Lingote mejorado.
ES1044838Y (es) Friegasuelos.
ITDP980002A1 (it) Vedi descrizione.
ES1039413Y (es) Nueva ficha-deportista.
ITDP980003A1 (it) Nessuna.
ES1037954Y (es) Cotilo semiexpansivo.
IT1295228B1 (it) Radio - bisturi.